Magnolia and Its Effect on Cannabinoid Receptors

For those of you following the NN lifestyle and for those of just starting, we like to help educate about the Endocannabinoid System (ECS) and how to best get it to work as it is intended.  Being most people do not have a functioning ECS, it becomes really important to help people with activating the system and at Noetic, we eagerly accept this task.

With that being sad, many  foods and ingredients we consume help our ECS on many levels.  Although we know that CBD may likely the best way activate and prime the system, there are other ways to enhance the effectiveness of CBD and even help the system independently.

Traditionally, in regions of Asia, the bark of the Magnolia Officanalis has been used for a host of medicinal applications.  These include but are not limited to helping people with anxiety, sleeping disorders, allergies, and other ‘diseases’.  Based on the results of the study discussed below, I’d venture to guess that it was also used for pain and inflammation based on the CB2 receptor interaction that was determined.

Research now shows that a great way a to activate the Endocannabinoid System (ECS) is with Magnolia Extracts.  There are actually two extracts that are commonly studied: magnolol and honokiol.  It appears that magnolol aids in CB2 activity with only a bit of an effect on the CB1 receptor while honokiol, being less potent, works to stimulate the CB1 receptors while mildly perhaps inhibiting CB2 receptor activity.  A study in ACS Medical Chemistry Letters, by Victor Rempel et. al, titled Magnolia Extract, Magnolol, and Metabolites Activation of Cannabinoid CB2 Receptors ad Blockade of the Related GPR55, shows just how this happens.

Is it possible to isolate each of these ingredients?  Yes.  Would they have an effect on the ECS independently or combined with other ECS agonists?  Yes!

The study also investigated if the ‘nasty’ endocannabioid eating enzymes, FAAH and MAGL, were affected by magnolia extract.  In this case, the magnolia didn’t seem to do much.  So, whereas CBD eats the enzymes, magnolol affects receptors directly.  This is great information but we have to consider that if we have excessive FAAH and MAGL in our system, as most people do, we must reduce them, and this is where Cannabidiol (CBD) comes in.  It’s one thing to hit a receptor directly and it’s another to be sure  your body is operating at an optimal level.  We should all be working to enhance our health.

We are excited to see research going into this area of study as it will help us with our product formulations.  Having a history of hundreds, if not thousands, of years of use of a particular ingredient and learning its positive effects is a great guide for what we can do going forward.

The statements in this blog have not been evaluated by the Food and Drug Administration. No statement in this blog or specific product discussed are intended to diagnose, treat, cure, or prevent any disease.  This blog is for informational purposes only.  We ask  you to discuss all matters of this blog with your doctor before beginning use of any products herein discussed.

NNlifestyle.com is protected by Copyright laws.  If you wish to ‘share’ or post this blog content from www.nnlifestyle.com , you may do so provided you share/post it in its entirety and do not alter it  in any way. Should you wish to use this content in any other fashion, you must receive written (this can be email) permission before doing so.